Cohort study finds post-transplant disease recurrence in 41.5% of autoimmune liver disease recipients, indicating high recurrence risk without immediate survival detriment.
No takes yet. Share an insight, caveat, or question.
Diana Lorena Sánchez Monroy (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: